Ascentage Pharma Group International (HKG:6855)
50.90
+1.40 (2.83%)
At close: Jan 23, 2026
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 567 employees as of December 31, 2024. The number of employees decreased by 16 or -2.74% compared to the previous year.
Employees
567
Change (1Y)
-16
Growth (1Y)
-2.74%
Revenue / Employee
707.46K HKD
Profits / Employee
-2.10M HKD
Market Cap
18.73B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | 433 | 23 | 5.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genscript Biotech | 5,568 |
| Zai Lab | 1,869 |
| Keymed Biosciences | 1,469 |
| Biocytogen Pharmaceuticals (Beijing) | 1,117 |
| InnoCare Pharma | 1,089 |
| Everest Medicines | 665 |
| Mirxes Holding Company | 347 |
| Ascletis Pharma | 208 |
Ascentage Pharma Group International News
- 5 days ago - Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 10 days ago - Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - ASH 2025 | Updated Data for Ascentage Pharma's Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment - Benzinga
- 7 weeks ago - Ascentage Gets Regulatory Clearance In The US And Europe To Conduct POLARIS-1 Trial - Nasdaq
- 7 weeks ago - Ascentage Pharma To Launch Global Phase III Study Of Olverembatinib In Ph+ ALL - Nasdaq
- 2 months ago - This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
- 2 months ago - Ascentage Pharma Group (AAPG): Piper Sandler Initiates Coverage with Overweight Rating | AAPG ... - GuruFocus
- 5 months ago - Ascentage Pharma Group International (AAPG) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha